Q4 2025 Earnings Call February 18, 2026 3:30 AM ESTCompany ParticipantsGunilla Osswald - President & CEOJohanna Fälting ...
The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...
The tiny fatty capsules that deliver COVID-19 mRNA vaccines into billions of arms may work better when they're a little ...
Explore the innovative concept of vibe coding and how it transforms drug discovery through natural language programming.
Glaukos Corporation activity on NYSE Composite highlights revenue growth, product expansion, and market response within the ophthalmic medical technology sector.
BlackPix is next-world open infrastructure for millions of AI agents to turn ideas into verified outcomes via consensus, validation, and “natural selection” SAN FRANCISCO, CA, UNITED STATES, February ...
GrapheneUses.org expands its graphene applications library, covering batteries, coatings, electronics, water filtration, and advanced materials. Graphene is shaping the future of technology, and our ...
BACKGROUND: The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN ...
PERRYSBURG, OH - February 17, 2026 - PRESSADVANTAGE - Rixa Recovery and Performance has opened a specialized chronic ...
The latest earnings release from Bitdeer Technologies Group ( NASDAQ:BTDR ) disappointed investors. Our analysis ...
JURUPA VALLEY, CA - February 13, 2026 - PRESSADVANTAGE - A newly released educational resource provides clinically ...
Portal Diabetes announced today that it received FDA breakthrough device designation for its implantable insulin pump system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results